Skip to main content
Top
Published in: BMC Geriatrics 1/2012

Open Access 01-12-2012 | Research article

Radical cystectomy over the age of 75 is safe and increases survival

Authors: Stavros I Tyritzis, Ioannis Anastasiou, Konstantinos G Stravodimos, Aristeides Alevizopoulos, Anastasios Kollias, Antonios Balangas, Ioannis Katafigiotis, Ioannis Leotsakos, Dionysios Mitropoulos, Constantinos A Constantinides

Published in: BMC Geriatrics | Issue 1/2012

Login to get access

Abstract

Background

Radical cystectomy (RC) is probably underused in elderly patients due to a potential increased postoperative complication risk, as reflected by their considerable comorbidities. Our objective was to estimate the overall complication rate and investigate a potential benefit to patients over the age of 75 subjected to RC in terms of disease-free survival.

Methods

A total of 81 patients, 61 men and 20 women, from two urological departments, with a mean age of 79.2 ± 3.7 years, participated in the study. The mean follow-up period was 2.6 ± 1.6 years. All patients underwent RC with pelvic lymphadenectomy. An ileal conduit, an orthotopic ileal neobladder and cutaneous ureterostomies were formed in 48.1%, 6.2% and 45.7% of the patients, respectively. The perioperative and 90-day postoperative complications were recorded and classified according to the modified Clavien classification system. Survival plots were created based on the oncological outcome and several study parameters.

Results

The perioperative morbidity rate was 43.2%; the 90-day morbidity rate was 37%, while the 30-day, 90-day and overall mortality rates were 3.7%, 3.7% and 21%, respectively. Overall mortality rates were recorded at the final year of data gathering (2009). Increased age, increased body mass index (BMI), longer hospitalization and age-adjusted Charlson comorbidity index (ACCI) more than six, were associated with greater hazard for 90-day morbidity. The cumulative mortality / metastasis-free rates for one, two, three and five years were 88.7%, 77.5%, 70.4%, and 62.3%, respectively. Tumour stage and positive nodes were prognostic predictors for oncological outcome.

Conclusions

RC in patients over 75 is justified and feasible, due to acceptable complication rates and high 5-year cancer-specific survival, which support an aggressive approach. Prospective studies are needed for the verification of the above results.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Clegg LX, Ward E, et al: Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer. 2004, 101: 3-27. 10.1002/cncr.20288.CrossRefPubMed Jemal A, Clegg LX, Ward E, et al: Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer. 2004, 101: 3-27. 10.1002/cncr.20288.CrossRefPubMed
2.
go back to reference Clark PE, Stein JP, Groshen SG, et al: Radical cystectomy in the elderly: comparison of clinical outcomes between younger and older patients. Cancer. 2005, 104: 36-43. 10.1002/cncr.21126.CrossRefPubMed Clark PE, Stein JP, Groshen SG, et al: Radical cystectomy in the elderly: comparison of clinical outcomes between younger and older patients. Cancer. 2005, 104: 36-43. 10.1002/cncr.21126.CrossRefPubMed
3.
go back to reference Stenzl A, Cowan NC, De Santis M, et al: The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2009, 55: 815-825. 10.1016/j.eururo.2009.01.002.CrossRefPubMed Stenzl A, Cowan NC, De Santis M, et al: The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2009, 55: 815-825. 10.1016/j.eururo.2009.01.002.CrossRefPubMed
4.
go back to reference Hollenbeck BK, Miller DC, Taub D, et al: Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology. 2004, 64: 292-297. 10.1016/j.urology.2004.03.034.CrossRefPubMed Hollenbeck BK, Miller DC, Taub D, et al: Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology. 2004, 64: 292-297. 10.1016/j.urology.2004.03.034.CrossRefPubMed
5.
go back to reference Wehrberger C, Berger I, Marszalek M, et al: Bladder preservation in octogenarians with invasive bladder cancer. Urology. 2010, 75: 370-375. 10.1016/j.urology.2009.10.027.CrossRefPubMed Wehrberger C, Berger I, Marszalek M, et al: Bladder preservation in octogenarians with invasive bladder cancer. Urology. 2010, 75: 370-375. 10.1016/j.urology.2009.10.027.CrossRefPubMed
6.
go back to reference Martin RC, Brennan MF, Jaques DP: Quality of complication reporting in the surgical literature. Ann Surg. 2002, 235: 803-813. 10.1097/00000658-200206000-00007.CrossRefPubMedPubMedCentral Martin RC, Brennan MF, Jaques DP: Quality of complication reporting in the surgical literature. Ann Surg. 2002, 235: 803-813. 10.1097/00000658-200206000-00007.CrossRefPubMedPubMedCentral
7.
go back to reference Dindo D, Demartines N, Clavien PA: Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004, 240: 205-213. 10.1097/01.sla.0000133083.54934.ae.CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA: Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004, 240: 205-213. 10.1097/01.sla.0000133083.54934.ae.CrossRefPubMedPubMedCentral
8.
go back to reference Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S: An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer. 2004, 4: 94-10.1186/1471-2407-4-94.CrossRefPubMedPubMedCentral Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S: An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer. 2004, 4: 94-10.1186/1471-2407-4-94.CrossRefPubMedPubMedCentral
9.
go back to reference Koppie TM, Serio AM, Vickers AJ, et al: Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer. 2008, 112: 2384-2392. 10.1002/cncr.23462.CrossRefPubMed Koppie TM, Serio AM, Vickers AJ, et al: Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer. 2008, 112: 2384-2392. 10.1002/cncr.23462.CrossRefPubMed
10.
go back to reference Boström PJ, Kössi J, Laato M, Nurmi M: Risk factors for mortality and morbidity related to radical cystectomy. BJU Int. 2009, 103: 191-196. 10.1111/j.1464-410X.2008.07889.x.CrossRefPubMed Boström PJ, Kössi J, Laato M, Nurmi M: Risk factors for mortality and morbidity related to radical cystectomy. BJU Int. 2009, 103: 191-196. 10.1111/j.1464-410X.2008.07889.x.CrossRefPubMed
11.
go back to reference Froehner M, Brausi MA, Herr HW, Muto G, Studer UE: Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol. 2009, 56: 443-454. 10.1016/j.eururo.2009.05.008.CrossRefPubMed Froehner M, Brausi MA, Herr HW, Muto G, Studer UE: Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol. 2009, 56: 443-454. 10.1016/j.eururo.2009.05.008.CrossRefPubMed
12.
go back to reference Shabsigh A, Korets R, Vora KC, et al: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009, 55: 164-176. 10.1016/j.eururo.2008.07.031.CrossRefPubMed Shabsigh A, Korets R, Vora KC, et al: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009, 55: 164-176. 10.1016/j.eururo.2008.07.031.CrossRefPubMed
13.
go back to reference Chahal R, Sundaram SK, Iddenden R, Forman DF, Weston PMT, Harrison SCW: A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol. 2003, 43: 246-257. 10.1016/S0302-2838(02)00581-X.CrossRefPubMed Chahal R, Sundaram SK, Iddenden R, Forman DF, Weston PMT, Harrison SCW: A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol. 2003, 43: 246-257. 10.1016/S0302-2838(02)00581-X.CrossRefPubMed
14.
go back to reference Crawford ED, Skinner DG: Salvage cystectomy after irradiation failure. J Urol. 1980, 123: 32-34.PubMed Crawford ED, Skinner DG: Salvage cystectomy after irradiation failure. J Urol. 1980, 123: 32-34.PubMed
15.
go back to reference Smith JA, Whitmore WF: Salvage cystectomy for bladder cancer after failure of definitive irradiation. J Urol. 1981, 125: 643-645.PubMed Smith JA, Whitmore WF: Salvage cystectomy for bladder cancer after failure of definitive irradiation. J Urol. 1981, 125: 643-645.PubMed
16.
go back to reference Sogni F, Brausi M, Frea B, et al: Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. Urology. 2008, 71: 919-923. 10.1016/j.urology.2007.11.125.CrossRefPubMed Sogni F, Brausi M, Frea B, et al: Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. Urology. 2008, 71: 919-923. 10.1016/j.urology.2007.11.125.CrossRefPubMed
17.
go back to reference Barbieri CE, Lee B, Cookson MS, et al: Association of procedure volume with radical cystectomy outcomes in a nationwide database. J Urol. 2007, 178: 1418-1421. 10.1016/j.juro.2007.05.156.CrossRefPubMed Barbieri CE, Lee B, Cookson MS, et al: Association of procedure volume with radical cystectomy outcomes in a nationwide database. J Urol. 2007, 178: 1418-1421. 10.1016/j.juro.2007.05.156.CrossRefPubMed
18.
go back to reference Nielsen ME, Shariat SF, Karakiewicz PI, et al: Bladder Cancer Research Consortium (BCRC). Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol. 2007, 5: 699-706.CrossRef Nielsen ME, Shariat SF, Karakiewicz PI, et al: Bladder Cancer Research Consortium (BCRC). Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol. 2007, 5: 699-706.CrossRef
19.
go back to reference Resorlu B, Beduk Y, Baltaci S, Ergun G, Talas H: The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy. BJU Int. 2009, 103: 480-483. 10.1111/j.1464-410X.2008.08033.x.CrossRefPubMed Resorlu B, Beduk Y, Baltaci S, Ergun G, Talas H: The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy. BJU Int. 2009, 103: 480-483. 10.1111/j.1464-410X.2008.08033.x.CrossRefPubMed
20.
go back to reference Chamie K, Hu B, Devere White RW, Ellison LM: Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians?. BJU Int. 2008, 102: 284-290. 10.1111/j.1464-410X.2008.07636.x.CrossRefPubMed Chamie K, Hu B, Devere White RW, Ellison LM: Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians?. BJU Int. 2008, 102: 284-290. 10.1111/j.1464-410X.2008.07636.x.CrossRefPubMed
21.
go back to reference Thrasher JB, Frazier HA, Robertson JE, Dodge RK, Paulson DF: Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer. 1994, 73: 1708-1715. 10.1002/1097-0142(19940315)73:6<1708::AID-CNCR2820730626>3.0.CO;2-J.CrossRefPubMed Thrasher JB, Frazier HA, Robertson JE, Dodge RK, Paulson DF: Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer. 1994, 73: 1708-1715. 10.1002/1097-0142(19940315)73:6<1708::AID-CNCR2820730626>3.0.CO;2-J.CrossRefPubMed
Metadata
Title
Radical cystectomy over the age of 75 is safe and increases survival
Authors
Stavros I Tyritzis
Ioannis Anastasiou
Konstantinos G Stravodimos
Aristeides Alevizopoulos
Anastasios Kollias
Antonios Balangas
Ioannis Katafigiotis
Ioannis Leotsakos
Dionysios Mitropoulos
Constantinos A Constantinides
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2012
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/1471-2318-12-18

Other articles of this Issue 1/2012

BMC Geriatrics 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.